She wanted to be a mom. So she chose a cancer treatment that gave her a chance

Even as a child, Maggie Loucks believed being a mom was her destiny.

“It was always inherently who I was,” says Loucks, of her tendency to take care of others. “Friends always turned to me and would always joke that I was the mom of the group.”

So when Loucks got a breast cancer diagnosis at age 28, her thoughts immediately ran to the kids she’d always wanted.

“After the initial shock of the diagnosis, that was the most present thing on my mind,” says Loucks, who was a newly married nursing student in Boston at the time.

The thought of not having her own biological children with her husband gutted her.

“And that was really almost harder than the treatment for breast cancer,” she says.

The type of cancer Loucks had, known as HER2-positive, is increasing at alarming rates among young women. This cancer is sensitive to hormones, and tends to spread quickly. Loucks was told that in the past, treatments had to match the cancer in harshness, and the toxins damaged ovaries and other organs in the process.

Loucks, who became an oncology nurse practitioner, refers to this as the “kitchen sink” approach: “You throw the kitchen sink at them; you give them every type of chemotherapy because you do not want this coming back.”

Less collateral damage

But treatments are rapidly changing. Medical breakthroughs, and genetics in particular, are enabling new drugs to better target specific subtypes of cancers, which not only dramatically increases chances of survival, it spares the body a lot of collateral damage. That, in turn, means some patients can choose how to address their cancer in ways that take into account their emotional and physical quality of life, after treatment.

Medicines that improve the quality of life in survivorship are the new frontier in treating cancer, says Dr. Ann Partridge, acting chair of oncology at Dana-Farber Cancer Institute and Maggie Loucks’s oncologist.

“We need to do more to improve those psychosocial outcomes and not only survive their cancer, but thrive after,” she says.

For nearly half of Partridge’s young adult patients, that includes trying to preserve fertility. Her research shows many women could treat their breast cancer for roughly two years — then pause to get pregnant — and resume treatment after giving birth without additional risk of cancer recurrence.

“Not only was that feasible and the vast majority of women were able to get pregnant and have a live birth, but it also appeared safe,” she says.

Maggie Loucks, photographed during a chemotherapy treatment, was a newlywed and a nursing student when she was diagnosed with hormone-receptor-positive and HER2-positive breast cancer.
Maggie Loucks, photographed during a chemotherapy treatment, was a newlywed and a nursing student when she was diagnosed with hormone-receptor-positive and HER2-positive breast cancer. (Loucks Family)

Partridge offered Loucks another alternative — a chemotherapy regimen that’s less aggressive in killing cancer cells and does less damage to ovaries, potentially preserving fertility. Loucks chose that route and harvested her eggs before treatment for good measure.

“I went into my chemotherapy with 15 embryos and I was so excited – elated,” she says.

Still, a fertility struggle

After five and a half years of treatment, Loucks and her husband finally began transferring their frozen embryos. One by one, they perished or failed to implant. Several times Loucks miscarried. Meanwhile, her friends were having babies, and she began to despair: “I was utterly devastated. So traumatizing. It was years and years of heartache and sadness.”

Because her ovaries remained healthy, Loucks was able to harvest more eggs. After two years of in-vitro fertilization, Loucks gave birth to twin daughters, Sloane and Everly. Two years after that, she conceived another girl, Kingsley, naturally.

“I don’t know if I would’ve gotten the same result, if I’d gotten the other chemotherapy,” says Loucks, now 40 and living in London with her family. She remains cancer free, and worries less about recurrence as time goes on.

Maggie Loucks conceived twins, Sloane and Everly, through IVF at age 36 and her third daughter, Kingsley, without medical intervention at age 38. The Loucks family now lives in London.
Maggie Loucks conceived twins, Sloane and Everly, through IVF at age 36 and her third daughter, Kingsley, without medical intervention at age 38. The Loucks family now lives in London. (Loucks Family)

Yet occasionally she wonders about her choice to take the less aggressive chemotherapy: “Am I going to regret this? What if my cancer comes back and I made the wrong choice? Now that I have kids, I have a different kind of fear. I want to be around for as long as possible.”

Gratitude and perspective

But not a day goes by that she doesn’t appreciate her past struggle, she says. She put her experiences to good use professionally when she worked with her former doctor, Ann Partridge, helping other women deal with fertility through cancer. And it has had a profound effect emotionally.

“Understanding and realizing how precious life can be is one beautiful thing from my cancer diagnosis that I’ve tried to hold onto,” says Loucks.

Katie Hayes Luke edited the visuals for this story.

 

Government shuts down after Congress fails to reach a funding agreement

Much of the federal government is now shut down after Republicans and Democrats in the Senate failed to agree on a funding plan to keep the government open.

Issues/Program Report 3rd Quarter 2025

October 1, 2025 Per the FCC, this is a list of the most frequently cited issues of concern to the people in the WBHM listening area during the last quarter. […]

Change is brewing in the coffee industry. What lies ahead?

Coffee growers are facing climate change, labor shortages and incomes below the poverty line. On International Coffee Day, we take stock of the industry behind the beverage.

President announces TrumpRx website for drugs, and pricing deal with Pfizer

The Trump administration says it is making deals with drug companies to lower prices U.S. consumers pay for medicines. But key details are missing on how the initiative would work.

Trump administration uses taxpayer dollars to blame Democrats for government shutdown

Federal employees across the government reported seeing similar messages. Experts say the messages may violate ethics laws meant to keep partisan politics out of day-to-day governing.

A lawsuit tries to block the Trump administration’s efforts to merge personal data

A class action lawsuit argues that the administration's efforts to combine databases of personal information on Americans violates privacy laws and the Constitution.

More Front Page Coverage